TradingView
RocketTickers
Oct 15, 2019 4:15 PM

Akorn Receives FDA Approval for Betamethasone Dipropionate Loti Long

NASDAQ:AKRX1D

Description

⋅
AKRX: Akorn, Inc.
2019-10-14 16:25:00
Akorn Receives FDA Approval for Betamethasone Dipropionate Lotion USP (Augmented), 0.05%
Beyond Technical Analysis
More